Breakthrough pain (BTP) arising due to rib metastasis is very distressing and often very difficult to manage by titration of traditional analgesics. This study is undertaken to determine the efficacy of radiofrequency (RF) treatment of intercostal nerves for the prevention of BTP.
Methods:
The RF treatment of the intercostal nerves was carried out in 25 patients with uncontrolled BTP arising out of the rib metastasis. The intensity and episode of BTP, background pain, opioid dose, functional status (Karnofky score), and quality of life (Short-Form Health Survey [SF-36]) were noted at baseline visit and subsequently after the RF treatment.
Results:
After the RF treatment, there was more than 50% decrease in both intensity and frequency of BTP in more than 50% of patients for 3 months, and there was more than 50% decrease in BTP opioid dose in more than 50% of patients throughout the study period. There was also significant improvement in background pain, functional status, and the quality of life after the RF. Interestingly, pain relief, lowering of opioid dose, and functional status improvement were found mostly in patients with mixed and neuropathic type of pain and in patients in whom the metastasis were confined to the ribs only.
Conclusion:
RF of the intercostal nerves is effective in preventing and deceasing the severity of BTP arising due to rib metastasis in selected group of patients with mixed and neuropathic type of pain and with the metastasis involving the ribs only.
BodyJJ. Metastatic bone disease: clinical and therapeutical aspects. Bone. 1992;13(suppl 1):557–562.
2.
PortenoyRKPayneDJacobsenP. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81(1-2):129–134.
3.
ZeppetellaG. Evidence-based treatment of cancer-related breakthrough pain with opioids. J Natl Compr Canc Netw. 2013;11(suppl 1):S37–S43.
4.
ZeppetellaGDaviesAN. Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev. 2013;10:CD004311.
5.
ZeppetellaG. Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project. Palliat Med. 2011;25(5):516–524.
6.
KuoKLSaokaewSStenehjemDD. The pharmacoeconomics of breakthrough cancer pain. J Pain Palliat Care Pharmacother. 2013;27(2):167–175.
7.
ClearyJPowellRAMuneneGMwangi-PowellFNLuyirikaEKiyangeFMerrimanAScholtenWRadbruchLTorodeJChernyNI. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol. 201310;24Suppl 11: xi14–23.
8.
ClearyJSilbermannMScholtenWRadbruchLTorodeJChernyNI. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol. 2013;24(suppl 11):xi51–xi59.
9.
ClearyJRadbruchLTorodeJChernyNI. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol. 2013;24(suppl 11):xi24–xi32.
10.
McQuayHJCollinsSLCarrollDMooreRA. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 2000;(2):CD001793.
11.
RoquéIFigulsMMartinez-ZapataMJScott-BrownMAlonso-CoelloP. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev. 2011;(7):CD003347.
12.
HillnerBEIngleJNChlebowskiRT. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health. J Clin Oncol. 2003;21(21):4042–4057.
KoyyalaguntaDBurtonAW. The role of chemical neurolysis in cancer pain. Curr Pain Headache Rep. 2010;14(4):261–267.
15.
MiliauskasPCicenasSTikuisisR. Intercostal nerve blockade with alcohol during operation for postthoracotomy pain. Medicina (Kaunas). 2004;40(suppl 1):127–130.
16.
WongFCLeeTWYuenKKLoSHSzeWKTungSY. Intercostal nerve blockade for cancer pain: effectiveness and selection of patients. Hong Kong Med J. 2007;13(4):266–270.
17.
KowalewskiRSchurchBHodlerJBorgeatA. Persistent paraplegia after an aqueous 7.5% phenol solution to the anterior motor root for intercostal neurolysis: a case report. Arch Phys Med Rehabil. 2002;83(2):283–285.
18.
EngelAJ. Utility of intercostal nerve conventional thermal radiofrequency ablations in the injured worker after blunt trauma. Pain Physician. 2012;15(5):E711–E718.
19.
BouhassiraDAttalNAlchaarH. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29–36.
20.
WareJESherbourneCD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473–483.
21.
DaviesNGibbonsEMackintoshA. A Structured Review of Patient-Reported Outcome Measures for Women with Breast Cancer. Oxford, UK: Patient-reported Outcome Measurement Group, Department of Public Health, University of Oxford; 2009.
22.
BakerFHafferSCDennistonM. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer. 2003;97(3):674–681.
23.
Wei-LiLinBo-FengLinChen-HwanCherng. Pulsed radiofrequency therapy for relieving neuropathic bone pain in cancer patients. J Med Sci. 2014;34(2):84–87.
24.
LordSMBarnsleyLWallisBJMcDonaldGJBogdukN. Percutaneous radiofrequency neurotomy for chronic cerival zygapophyseal joint pain. N Engl J Med. 1996;335(23):1721–1726.
25.
Van KleefMBarendseGAKesselsAVoetsHMWeberWEde LangeS. Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain. Spine. 1999;24(18):1937–1942.
26.
WallisBJLordSMBogdukN. Resolution of psychological distress of whiplash patients following treatment by radiofrequency neurotomy: a randomized, double-blind, placebo-controlled trial. Pain. 1997;73(1):15–22.
27.
Van KleefMLiemLLousbergRBarendseGKesselsFSluijterM. Radiofrequency lesion adjacent to the dorsal root ganglion for cervicobrachial pain: a prospective double blind randomized study. Neurosurgery. 1996:38(6):1127–1131: discussion 1131-1132.
28.
SlappendelRCrulBJBraakGJ. The efficacy of radiofrequency lesioning of the cervical spinal dorsal root ganglion in a double blinded randomized study: no difference between 40 degrees C and 67 degrees C treatments. Pain. 1997;73(2):159–163.
29.
SamwelHSlappendelRCrulBJVoermanVF. Psychological predictors of the effectiveness of radiofrequency lesioning of the cervical spinal dorsal ganglion (RF-DRG). Eur J Pain. 2000;4(2):149–155.
30.
LopezBCHamynPJZakrzewskaJM. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurgery. 2004;54(4):973–982.
31.
CohenSPHurleyRWBuckenmaierCCIIIKuriharaCMorlandoBDragovichA. Randomized placebo-controlled study evaluating lateral branch radiofrequency denervation for sacroiliac joint pain. Anesthesiology. 2008;109(2):279–288.
32.
SasaiTSakakibaraSKajiM. Management of pain after thoracotomy: experience of intercostal nerve block with alcohol during operation. Kyobu Geka. 1991;44(2):132–134.
33.
GreenCRDeRosayroAMTaitAP. Longterm follow-up of cryoanalgesia for chronic thoracic pain. Reg Anesth. 1993;18(2):46.
34.
JonesMMuffinKR. Intercostal block with cryotherapy. Ann R Coll Sug Engl. 1987;69(6):261–262.
35.
ShankarHEastwoodD. Retrospective comparison of ultrasound and fluoroscopic image guidance for intercostal steroid injections. Pain Pract. 2010;10(4):312–317.
36.
ShantiCMCarlinAMTyburskiJG. Incidence of pneumothorax from intercostal nerve block for analgesia in rib fractures. J Trauma. 2001;51(3):536–539.
37.
GazelkaHMKnievelSMauckWD. Incidence of neuropathic pain after radiofrequency denervation of the third occipital nerve. J Pain Res. 2014;7:195–198.
38.
GovindJKingWBaileyBBogdukN. Radiofrequency neurotomy for the treatment of third occipital headache. J Neurol Neurosurg Psychiatry. 2003;74(1):88–93.
39.
StolzenbergDGordinVVorobeychikY. Incidence of neuropathic pain after cooled radiofrequency ablation of sacral lateral branch nerves. Pain Med. 2014;15(11):1857–1860.
